Location: Minnetonka, MN
CIK: 0001683689 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 16, 2022
Total Value: $142M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| — | Horizon Therapeutics Public Limited Company | 544,043 | $43.39M | 30.5% | $79.76 | $68.27 | — | SHS | G46188101 |
| IEFA | ISHARES TR | 390,722 | $22.99M | 16.2% | $58.85 | $73.07 | -19.5% | CORE MSCI EAFE | 46432F842 |
| FIVN | Five9, Inc. | 174,478 | $15.9M | 11.2% | $91.14 | $120.22 | -24.2% | COM | 338307101 |
| — | JAMF HOLDING CORP | 621,243 | $15.39M | 10.8% | $24.77 | $35.90 | — | COM | 47074L105 |
| IEMG | ISHARES TR | 304,745 | $14.95M | 10.5% | $49.06 | $65.22 | -24.8% | CORE MSCI EMKT | 46434G103 |
| VCEL | Vericel Corporation | 552,973 | $13.92M | 9.8% | $25.18 | $15.89 | +58.5% | COM | 92346J108 |
| NEO | NeoGenomics Inc. | 1,615,513 | $13.17M | 9.2% | $8.15 | $23.81 | -65.8% | COM NEW | 64049M209 |
| MITK | MITEK SYS INC | 251,055 | $2.32M | 1.6% | $9.24 | $18.39 | -49.7% | COM NEW | 606710200 |
| ISTB | ISHARES TR | 2,228 | $106K | 0.1% | $47.58 | $51.50 | -8.0% | CORE 1 5 YR USD | 46432F859 |
| IVV | ISHARES TR | 234 | $89,000 | 0.1% | $380.34 | $332.80 | +13.9% | CORE S&P500 ETF | 464287200 |
| IAGG | ISHARES TR | 862 | $43,000 | 0.0% | $49.88 | $55.61 | -10.4% | CORE INTL AGGR | 46435G672 |
| IMTB | ISHARES TR | 834 | $37,000 | 0.0% | $44.36 | $52.30 | -14.4% | CR 5 10 YR ETF | 46435G417 |
| IJH | ISHARES TR | 122 | $28,000 | 0.0% | $229.51 * | $37.39 | +21.0% | CORE S&P MCP ETF | 464287507 |
| IJR | ISHARES TR | 169 | $16,000 | 0.0% | $94.67 * | $71.67 | +28.9% | CORE S&P SCP ETF | 464287804 |